Melorheostosis with osteopoikilosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1879OMIM:166700M85.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Melorheostosis with osteopoikilosis is a rare mixed sclerosing bone dysplasia that combines features of two distinct skeletal conditions. Melorheostosis is characterized by flowing hyperostosis (excessive bone formation) along the cortex of long bones, producing a distinctive 'dripping candle wax' appearance on X-rays. Osteopoikilosis refers to the presence of multiple small, round or oval sclerotic foci (bone islands) scattered throughout the epiphyses and metaphyses of bones. When these two conditions occur together, they are considered part of the spectrum of mixed sclerosing bone dystrophies, sometimes also associated with other sclerosing bone conditions such as osteopathia striata. The condition primarily affects the skeletal system, particularly the long bones of the limbs, pelvis, and small bones of the hands and feet. Key clinical features include bone pain, joint stiffness, limb asymmetry, and restricted range of motion. Soft tissue abnormalities may also occur, including skin changes overlying affected bones (such as linear scleroderma-like patches), joint contractures, and soft tissue masses. The melorheostotic component tends to be more symptomatic, causing pain and functional limitation, while osteopoikilosis is often an incidental radiographic finding that is typically asymptomatic. Some cases have been associated with mutations in the MAP2K1 gene (somatic) for the melorheostosis component, while osteopoikilosis has been linked to germline loss-of-function mutations in the LEMD3 gene (also known as MAN1), which encodes an inner nuclear membrane protein involved in TGF-beta and BMP signaling. Treatment is primarily symptomatic and supportive, including pain management with analgesics and anti-inflammatory medications, physical therapy to maintain joint mobility, and surgical intervention in severe cases for correction of deformities or release of contractures. There is no cure, and management focuses on preserving function and quality of life.

Also known as:

Clinical phenotype terms— hover any for plain English:

Complete duplication of the distal phalanges of the handHP:0010001OsteopoikilosisHP:0010739
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Melorheostosis with osteopoikilosis.

View clinical trials →

No actively recruiting trials found for Melorheostosis with osteopoikilosis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Melorheostosis with osteopoikilosis community →

No specialists are currently listed for Melorheostosis with osteopoikilosis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Melorheostosis with osteopoikilosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Melorheostosis with osteopoikilosisForum →

No community posts yet. Be the first to share your experience with Melorheostosis with osteopoikilosis.

Start the conversation →

Latest news about Melorheostosis with osteopoikilosis

1 articles
Clinical trialCLINICALTRIALSMar 26, 2026
Trial Now Recruiting: Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease (NCT02504879)
Researchers are looking for people with melorheostosis, a rare disease where bones become abnormally thick and hard, to join a study. The study will follow part
See all news about Melorheostosis with osteopoikilosis

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Melorheostosis with osteopoikilosis

What is Melorheostosis with osteopoikilosis?

Melorheostosis with osteopoikilosis is a rare mixed sclerosing bone dysplasia that combines features of two distinct skeletal conditions. Melorheostosis is characterized by flowing hyperostosis (excessive bone formation) along the cortex of long bones, producing a distinctive 'dripping candle wax' appearance on X-rays. Osteopoikilosis refers to the presence of multiple small, round or oval sclerotic foci (bone islands) scattered throughout the epiphyses and metaphyses of bones. When these two conditions occur together, they are considered part of the spectrum of mixed sclerosing bone dystrophi